CORAL GABLES, Fla., Sept. 3, 2013 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), a specialty pharmaceutical company focused on the development and commercialization of novel prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, today announced that Patrick J. McEnany, Chief Executive Officer, and Dr. Steven Miller, Chief Operating Officer and Chief Scientific Officer, will be presenting at Rodman & Renshaw’s 15th Annual Global Investment Conference, which is being held on September 8-10, 2013 at The Millennium Broadway Hotel in New York, NY.
Help employers find you! Check out all the jobs and post your resume.
